The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Zestoretic 10 mg /12.5 mg Tablets

Atnahs Pharma Netherlands B.V.PA23140/001/001

Main Information

Trade NameZestoretic 10 mg /12.5 mg Tablets
Active SubstancesLisinopril Dihydrate
Dosage FormTablet
Licence HolderAtnahs Pharma Netherlands B.V.
Licence NumberPA23140/001/001

Group Information

ATC CodeC09BA ACE inhibitors and diuretics
C09BA03 lisinopril and diuretics


License statusAuthorised
Licence Issued13/03/2000
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back